Buscemi G - Search Results

1

REGgamma proteasome activator is involved in the maintenance of chromosomal stability.

Zannini L, Lecis D, Buscemi G, Carlessi L, Gasparini P, Fontanella E, Lisanti S, Barton L, Delia D. Zannini L, et al. Among authors: buscemi g. Cell Cycle. 2008 Feb 15;7(4):504-12. doi: 10.4161/cc.7.4.5355. Epub 2007 Nov 23. Cell Cycle. 2008. PMID: 18235248

2

Chk2 activation dependence on Nbs1 after DNA damage.

Buscemi G, Savio C, Zannini L, Miccichè F, Masnada D, Nakanishi M, Tauchi H, Komatsu K, Mizutani S, Khanna K, Chen P, Concannon P, Chessa L, Delia D. Buscemi G, et al. Mol Cell Biol. 2001 Aug;21(15):5214-22. doi: 10.1128/MCB.21.15.5214-5222.2001. Mol Cell Biol. 2001. PMID: 11438675 Free PMC article.

3

Karyopherin-alpha2 protein interacts with Chk2 and contributes to its nuclear import.

Zannini L, Lecis D, Lisanti S, Benetti R, Buscemi G, Schneider C, Delia D. Zannini L, et al. Among authors: buscemi g. J Biol Chem. 2003 Oct 24;278(43):42346-51. doi: 10.1074/jbc.M303304200. Epub 2003 Aug 9. J Biol Chem. 2003. PMID: 12909615 Free article.

4

MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder.

Delia D, Piane M, Buscemi G, Savio C, Palmeri S, Lulli P, Carlessi L, Fontanella E, Chessa L. Delia D, et al. Among authors: buscemi g. Hum Mol Genet. 2004 Sep 15;13(18):2155-63. doi: 10.1093/hmg/ddh221. Epub 2004 Jul 21. Hum Mol Genet. 2004. PMID: 15269180

5

Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks.

Buscemi G, Perego P, Carenini N, Nakanishi M, Chessa L, Chen J, Khanna K, Delia D. Buscemi G, et al. Oncogene. 2004 Oct 7;23(46):7691-700. doi: 10.1038/sj.onc.1207986. Oncogene. 2004. PMID: 15361830

6

DNA damage-induced cell cycle regulation and function of novel Chk2 phosphoresidues.

Buscemi G, Carlessi L, Zannini L, Lisanti S, Fontanella E, Canevari S, Delia D. Buscemi G, et al. Mol Cell Biol. 2006 Nov;26(21):7832-45. doi: 10.1128/MCB.00534-06. Epub 2006 Aug 28. Mol Cell Biol. 2006. PMID: 16940182 Free PMC article.

7

Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2.

Carlessi L, Buscemi G, Larson G, Hong Z, Wu JZ, Delia D. Carlessi L, et al. Among authors: buscemi g. Mol Cancer Ther. 2007 Mar;6(3):935-44. doi: 10.1158/1535-7163.MCT-06-0567. Mol Cancer Ther. 2007. PMID: 17363488

8

The shelterin protein TRF2 inhibits Chk2 activity at telomeres in the absence of DNA damage.

Buscemi G, Zannini L, Fontanella E, Lecis D, Lisanti S, Delia D. Buscemi G, et al. Curr Biol. 2009 May 26;19(10):874-9. doi: 10.1016/j.cub.2009.03.064. Epub 2009 Apr 16. Curr Biol. 2009. PMID: 19375317 Free article.

9

REGgamma/PA28gamma proteasome activator interacts with PML and Chk2 and affects PML nuclear bodies number.

Zannini L, Buscemi G, Fontanella E, Lisanti S, Delia D. Zannini L, et al. Among authors: buscemi g. Cell Cycle. 2009 Aug;8(15):2399-407. doi: 10.4161/cc.8.15.9084. Epub 2009 Aug 21. Cell Cycle. 2009. PMID: 19556897

10

A protein phosphatase feedback mechanism regulates the basal phosphorylation of Chk2 kinase in the absence of DNA damage.

Carlessi L, Buscemi G, Fontanella E, Delia D. Carlessi L, et al. Among authors: buscemi g. Biochim Biophys Acta. 2010 Oct;1803(10):1213-23. doi: 10.1016/j.bbamcr.2010.06.002. Epub 2010 Jun 22. Biochim Biophys Acta. 2010. PMID: 20599567 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters